🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the producers of acetaminophen, asserting the firms withheld alleged dangers that the pain reliever posed to children's neurological development.

The court filing comes four weeks after Donald Trump promoted an unproven link between taking acetaminophen - also known as acetaminophen - during pregnancy and autism spectrum disorder in offspring.

Paxton is suing J&J, which previously sold the drug, the only pain reliever suggested for women during pregnancy, and Kenvue, which presently makes it.

In a official comment, he stated they "deceived the public by making money from suffering and pushing pills regardless of the potential hazards."

The company asserts there is lacking scientific proof tying Tylenol to autism.

"These corporations deceived for years, intentionally threatening numerous people to increase profits," the attorney general, from the Republican party, declared.

The manufacturer stated officially that it was "seriously troubled by the perpetuation of misinformation on the reliability of acetaminophen and the potential impact that could have on the welfare of women and children in America."

On its online platform, Kenvue also stated it had "regularly reviewed the relevant science and there is no credible data that shows a proven link between consuming acetaminophen and autism spectrum disorder."

Associations speaking for medical professionals and medical practitioners share this view.

The leading OB-GYN organization has declared paracetamol - the main ingredient in Tylenol - is one of the few options for women during pregnancy to treat pain and elevated temperature, which can present significant medical dangers if not addressed.

"In more than two decades of investigation on the utilization of paracetamol in pregnancy, no reliable research has successfully concluded that the use of paracetamol in any period of gestation causes neurodevelopmental disorders in young ones," the association stated.

The lawsuit references latest statements from the previous government in asserting the medication is reportedly hazardous.

Recently, the former president caused concern from public health officials when he told pregnant women to "struggle intensely" not to take Tylenol when unwell.

The US Food and Drug Administration then issued a notice that physicians should think about restricting the use of acetaminophen, while also mentioning that "a direct connection" between the medication and autism in young ones has remains unverified.

The Health Department head Robert F Kennedy Jr, who oversees the Food and Drug Administration, had pledged in April to conduct "a massive testing and research effort" that would establish the origin of autism spectrum disorder in a short period.

But specialists advised that identifying a sole reason of autism spectrum disorder - thought by researchers to be the consequence of a complex mix of inherited and surrounding conditions - would be difficult.

Autism spectrum disorder is a category of lifelong neurodivergence and impairment that affects how people encounter and interact with the world, and is recognized using medical professional evaluations.

In his legal document, the attorney general - a Trump ally who is seeking federal office - alleges Kenvue and J&J "intentionally overlooked and sought to suppress the evidence" around acetaminophen and autism spectrum disorder.

This legal action attempts to require the firms "destroy any promotional materials" that asserts Tylenol is reliable for women during pregnancy.

The court case parallels the concerns of a collection of parents of young ones with autism and attention deficit hyperactivity disorder who filed suit against the manufacturers of Tylenol in two years ago.

Judicial authorities threw out the legal action, stating research from the family's specialists was lacking definitive proof.